| Abstrakt: |
A patent application by inventors from San Diego, CA, US, is in the approval process for systems and methods for automated insulin delivery for diabetes therapy. The application focuses on mitigating the risk of insulin stacking in automated insulin delivery systems, which can occur when insulin doses are automatically increased based on glucose levels and a manual meal bolus is later programmed. The invention aims to reduce the possibility of double dosing by modifying the meal bolus if it is programmed within a predetermined time of an automatically calculated insulin dose increase. The patent application emphasizes the importance of integrating continuous glucose monitoring devices with ambulatory infusion pumps to enhance diabetes therapy. [Extracted from the article] |
